[1]
tooran makhdoumi, “Intracoronary Versus Intravenous Administration of Eptifibatide During Percutaneous Coronary Intervention in Patients With Acute Coronary Syndromes”, Acta Med Iran, vol. 58, no. 7, pp. 332-339, Oct. 2020.